Paid Clinical Trials in Texas

Texas has 5,344 paid clinical trials enrolling now across cities including Houston, Dallas and San Antonio. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Texas include MD Anderson Cancer Center, Baylor College of Medicine and UT Southwestern, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 14, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

4,652 clinical trials

Get a weekly email when new trials open in Houston, TX.

Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).

for Juvenile Psoriatic Arthritis

Drug: Secukinumab

Sites in El Paso +10 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 2 - 17

Code: NCT06751238·Phase 1·Recruiting·Listed Dec 2024

Apply to this trial

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

for Hepatocellular Carcinoma

Sites in Dallas +4 more locations

Sponsor: Eureka Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT04864054·Phase 1, Phase 2·Recruiting·Listed Apr 2021

Apply to this trial

A Study of KK2269 in Adult Participants With Solid Tumors

for Advanced Solid Tumor

Sites in Dallas +6 more locations

Sponsor: Kyowa Kirin Co., Ltd.

Sex: All·Age: 18+

Code: NCT06266299·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

for Sickle Cell Disease

Sites in Houston +6 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 12 - 55·Accepts healthy volunteers

Code: NCT06546670·Phase 1, Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)

for Duchenne Muscular Dystrophy

Sites in Flower Mound +2 more locations

Sponsor: Solid Biosciences Inc.

Sex: Male·Age: 7 - 11

Code: NCT07160634·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass

for Weight Regain

Sites in Houston +8 more locations

Sponsor: Boston Scientific Corporation

Sex: All·Age: 18+

Code: NCT07015424·Recruiting·Listed Jun 2025

Apply to this trial

Danon Disease Natural History Study

for Danon Disease

Sites in Houston, Dallas +7 more locations

Sponsor: Rocket Pharmaceuticals Inc.

Sex: All·Age: 8+

Code: NCT06214507·Recruiting·Listed Jan 2024

Apply to this trial

Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis

for Low-grade Upper Tract Urothelial Carcinoma

Drug: Nadofaragene Firadenovec

Sites in Houston +8 more locations

Sponsor: Ferring Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06668493·Phase 1, Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

for Relapsing Remitting Multiple Sclerosis

Sites in Houston, Austin +7 more locations

Sponsor: SetPoint Medical Corporation

Sex: All·Age: 22 - 60

Code: NCT06796504·Recruiting·Listed Jan 2025

Apply to this trial

A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours

for Advanced Solid Tumor

Sites in Dallas +4 more locations

Sponsor: Ipsen

Sex: All·Age: 18+

Code: NCT06833008·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours

for Advanced Solid Tumor

Sites in Houston, San Antonio +5 more locations

Sponsor: Adcendo ApS

Sex: All·Age: 18+

Code: NCT06597721·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

for Pancreatic Ductal Adenocarcinoma

Sites in Houston, Dallas +5 more locations

Sponsor: PanTher Therapeutics

Sex: All·Age: 18+

Code: NCT06673017·Phase 1·Recruiting·Listed Nov 2024

Apply to this trial

SW-682 in Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Houston, Dallas +6 more locations

Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany

Sex: All·Age: 18+

Code: NCT06251310·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs

for Non-small Cell Lung Cancer (NSCLC)

Sites in Houston +1 more location

Sponsor: Pierre Fabre Medicament

Sex: All·Age: 18+

Code: NCT06567015·Phase 1, Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

for Neovascular (Wet) Age-related Macular Degeneration

Sites in Katy +2 more locations

Sponsor: Skyline Therapeutics

Sex: All·Age: 50+

Code: NCT06346600·Recruiting·Listed Apr 2024

Apply to this trial

First In Human Study of CX-801 in Advanced Solid Tumors

for Solid Tumor, Adult

Sites in Fort Worth +4 more locations

Sponsor: CytomX Therapeutics

Sex: All·Age: 18+

Code: NCT06462794·Phase 1·Recruiting·Listed Jun 2024

Apply to this trial

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

for Relapsed or Refractory Multiple Myeloma

Sites in Houston +8 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT05652335·Phase 1·Recruiting·Listed Dec 2022

Apply to this trial

Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

for Neovascular Age-related Macular Degeneration

Sites in Katy +3 more locations

Sponsor: Skyline Therapeutics (US) Inc.

Sex: All·Age: 50+

Code: NCT05986864·Phase 1, Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

for AML

Sites in Houston +4 more locations

Sponsor: CERo Therapeutics Holdings, Inc.

Sex: All·Age: 18 - 85

Code: NCT06834282·Phase 1·Recruiting·Listed Feb 2025

Apply to this trial

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

for Myeloid Leukemia, Philadelphia Positive

Sites in Houston +7 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 1 - 17

Code: NCT04925479·Phase 1, Phase 2·Recruiting·Listed Jun 2021

Apply to this trial

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

for Leukemia, Lymphocytic, Chronic, B-Cell

Drug: Nemtabrutinib

Sites in Sugar Land +14 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT05947851·Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

for Hemophilia B

Sites in Houston +3 more locations

Sponsor: CSL Behring

Sex: All·Age: 18+

Code: NCT06003387·Phase 3·Recruiting·Listed Aug 2023

Apply to this trial

Pharmacokinetic Study of Vorasidenib in Severe Hepatically Impaired and Matched-Control Participants

for Severe Hepatic Impairment

Drug: Vorasidenib

Sites in San Antonio +2 more locations

Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.)

Sex: All·Age: 18 - 75·Accepts healthy volunteers

Code: NCT07250633·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM

for Glioblastoma Multiforme

Sites in Houston +6 more locations

Sponsor: Boston Scientific Corporation

Sex: All·Age: 18+

Code: NCT05303467·Phase 1·Recruiting·Listed Mar 2022

Apply to this trial

A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

for Dermatomyositis

Sites in Houston, Frisco +1 more location

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT06698796·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

for Relapsed and/or Refractory Multiple Myeloma (RRMM)

Drug: Linvoseltamab

Sites in Houston +3 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07222761·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia

for Congenital Adrenal Hyperplasia

Sites in Dallas +12 more locations

Sponsor: Crinetics Pharmaceuticals Inc.

Sex: All·Age: 18 - 74

Code: NCT07144163·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

for Geographic Atrophy

Sites in Dallas, The Woodlands +3 more locations

Sponsor: AbbVie

Sex: All·Age: 50+

Code: NCT07160179·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

The WiSE®-UP Study (The WiSE System Utilization & Performance Study)

for Heart Failure

Sites in Austin +11 more locations

Sponsor: EBR Systems, Inc.

Sex: All·Age: 22+

Code: NCT07098858·Recruiting·Listed Aug 2025

Apply to this trial

Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)

for Ventricular Tachycardia (VT)

Sites in Austin +5 more locations

Sponsor: Medtronic Cardiac Ablation Solutions

Sex: All·Age: 18 - 85

Code: NCT06703489·Recruiting·Listed Nov 2024

Apply to this trial

Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases

for Leptomeningeal Metastasis

1 location in San Antonio

Sponsor: Cerenome

Sex: All·Age: 18+

Code: NCT07098806·Phase 1, Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

for Chronic Graft Versus Host Disease

Sites in Houston +4 more locations

Sponsor: Sanofi

Sex: All·Age: 1 - 18

Code: NCT07116031·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

for Primary Photoreceptor Disease

Sites in Dallas +4 more locations

Sponsor: BlueRock Therapeutics

Sex: All·Age: 18+

Code: NCT06789445·Phase 1, Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors

for Selected Types of Solid Tumor

Sites in Houston +2 more locations

Sponsor: Everest Medicines (Beijing) Co., Ltd.

Sex: All·Age: 18+

Code: NCT07095868·Phase 1, Phase 2·Recruiting·Listed Jul 2025

Apply to this trial

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

for Relapsed/Refractory Systemic Light Chain Amyloidosis

Drug: Linvoseltamab

Sites in Houston +7 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06292780·Phase 1, Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

AAV Gene Therapy Clinical Study in Adult Classic PKU (PHEdom)

for Phenylketonurias

Sites in Dallas +4 more locations

Sponsor: NGGT INC.

Sex: All·Age: 18 - 55

Code: NCT06332807·Phase 1, Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

AERA Pediatrics Registry

for Dysfunction of Eustachian Tube

Sites in Houston, Fort Worth +7 more locations

Sponsor: Integra LifeSciences Corporation

Sex: All·Age: Up to 18

Code: NCT07071298·Recruiting·Listed Jul 2025

Apply to this trial

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)

for Dry Eye Syndrome

Sites in Harlingen +6 more locations

Sponsor: AbbVie

Sex: All·Age: 18 - 75

Code: NCT06977724·Phase 1·Recruiting·Listed May 2025

Apply to this trial

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Houston, San Antonio +13 more locations

Sponsor: Vividion Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06004245·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial

for Cardiovascular Disease

Drug: Olpasiran

Sites in Humble +5 more locations

Sponsor: Amgen

Sex: All·Age: 35 - 80

Code: NCT07293260·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial